They demonstrated that the beta-catenin pathway regulates miR-21 expression in human umbilical vein endothelial cells and glioma cells and that this regulation is signal transducer and activator of transcription 3 (STAT3)-dependent. This evidence concerns the gene CTNNB1 and central nervous system cancer.